The aim of this study was to assess the impact of different definitions on the rates of post-treatment relapse and therefore on the probability of retreatment in such patients who discontinued effective long-term NAs therapy.

We investigated the patterns of serum HBsAg kinetics and their association with therapeutic outcomes in genotype B- or C-infected CHB patients receiving long-term NA therapy.

CRP showed to be a strong predictor of early hospital readmission and 6-month mortality in patients with cirrhosis after hospitalization for bacterial and/or fungal infection.

HCC replicating HBV represents a subtype of weakly invasive HCC with a transcriptomic signature.

This study investigated the potential to discontinue tenofovir disoproxil fumarate (TDF) therapy in HBeAg-negative patients.

Gao and colleagues evaluated the effect of antiviral therapy on the incidence of HCC in patients with cirrhosis with lower HBV DNA levels.

Early diagnosis of HBV through effective screening programs allows timely initiation of therapy to prevent disease progression and decompensation.

The pooled results from comparative trials (599 pregnancies) showed that tenofovir significantly reduced the risk of infant hepatitis B surface antigen seropositivity by 77% .

Medical management recommendations for severe alcoholic hepatitis

The China Food and Drug Administration (CFDA) has approved the country's first all-oral, interferon-and ribavirin-free direct-acting antiviral regimen for chronic hepatitis C virus (HCV) infection.